Stock

Aspira Pathlab & Diagnostics Limited

Healthcare Service Provider

Share price

₹138

Market cap

₹135 Cr

1Y return

▲ 120%

Aspira Pathlab & Diagnostics Limited is a Mumbai-based pathology and diagnostic healthcare services company established in 1973. It operates multiple diagnostic centers offering pathology tests, sonography, X-ray, 2D echocardiography, and specialized health screening packages. The company holds NABL accreditation and positions itself with over 50 years of experience in diagnostic services. It is listed on the BSE (code 540788) and serves patients through in-center and home-based blood collection services across India.

Recent moves 7

JAY ARVIND BHANUSHALI

24 Sept 2026. Sign in to see this move

JAY ARVIND BHANUSHALI

16 Sept 2026. Sign in to see this move

JAY ARVIND BHANUSHALIIncreased

Promoter Jay Arvind Bhanushali bought 74 shares of Aspira Pathlab & Diagnostics Limited through the open market. The purchase slightly increased his holding within his existing 7.25% stake, taking his total to 7,46,451 shares.

JAY ARVIND BHANUSHALIIncreased

Promoter Jay Arvind Bhanushali bought 623 shares of Aspira Pathlab & Diagnostics Limited in the open market, marginally increasing his holding to 7,46,377 shares, representing a 7.25% stake.

JAY ARVIND BHANUSHALIIncreased

Promoter Jay Arvind Bhanushali bought 957 shares of Aspira Pathlab & Diagnostics Limited in the open market, marginally increasing his stake from 7.24% to 7.25%.

JAY ARVIND BHANUSHALIIncreased

Jay Arvind Bhanushali, a promoter, bought 332 shares of Aspira Pathlab & Diagnostics via open market, increasing their stake from 7.23% to 7.24%.

Raj Arvind Bhanushali and PACs (promoter group)Increased

Raj Arvind Bhanushali and PACs acquired 22,82,507 shares of Aspira Pathlab & Diagnostics Limited for ₹27.53 Cr at ₹120.60 per share, raising their stake from 23.82% to 46.00% pursuant to an open offer.

Track the whales in Aspira Pathlab & Diagnostics Limited

Get alerted the moment a top investor buys or sells.